As HDAC inhibitors could return transcriptomic signature induced by chemotherapeutic drugs such as cytarabine to normal state and target leukemia stem cells population of cancer cells [49], they could have promising activity in combination with known anticancer drugs. Here, HDAC9 is linked to cancer.